β1-Integrin- and KV1.3 channel-dependent signaling stimulates glutamate release from Th17 cells.
Animals
Cell Communication
/ genetics
Glutamic Acid
/ genetics
Humans
Integrin beta1
/ genetics
Kv1.3 Potassium Channel
/ genetics
Mice
Mice, Knockout
Multiple Sclerosis
/ genetics
SNARE Proteins
/ genetics
Signal Transduction
/ genetics
Th17 Cells
/ immunology
Vascular Cell Adhesion Molecule-1
/ genetics
Autoimmunity
Ion channels
Multiple sclerosis
Neuroscience
T cells
Journal
The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877
Informations de publication
Date de publication:
03 02 2020
03 02 2020
Historique:
received:
26
11
2018
accepted:
22
10
2019
pubmed:
30
10
2019
medline:
15
9
2020
entrez:
30
10
2019
Statut:
ppublish
Résumé
Although the impact of Th17 cells on autoimmunity is undisputable, their pathogenic effector mechanism is still enigmatic. We discovered soluble N-ethylmaleimide-sensitive factor attachment receptor (SNARE) complex proteins in Th17 cells that enable a vesicular glutamate release pathway that induces local intracytoplasmic calcium release and subsequent damage in neurons. This pathway is glutamine dependent and triggered by binding of β1-integrin to vascular cell adhesion molecule 1 (VCAM-1) on neurons in the inflammatory context. Glutamate secretion could be blocked by inhibiting either glutaminase or KV1.3 channels, which are known to be linked to integrin expression and highly expressed on stimulated T cells. Although KV1.3 is not expressed in CNS tissue, intrathecal administration of a KV1.3 channel blocker or a glutaminase inhibitor ameliorated disability in experimental neuroinflammation. In humans, T cells from patients with multiple sclerosis secreted higher levels of glutamate, and cerebrospinal fluid glutamine levels were increased. Altogether, our findings demonstrate that β1-integrin- and KV1.3 channel-dependent signaling stimulates glutamate release from Th17 cells upon direct cell-cell contact between Th17 cells and neurons.
Identifiants
pubmed: 31661467
pii: 126381
doi: 10.1172/JCI126381
pmc: PMC6994160
doi:
pii:
Substances chimiques
Integrin beta1
0
Itgb1 protein, human
0
Itgb1 protein, mouse
0
KCNA3 protein, human
0
Kcna3 protein, mouse
0
Kv1.3 Potassium Channel
0
SNARE Proteins
0
Vascular Cell Adhesion Molecule-1
0
Glutamic Acid
3KX376GY7L
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
715-732Références
Sci Rep. 2016 Apr 15;6:24251
pubmed: 27080443
J Exp Med. 2000 Apr 3;191(7):1167-76
pubmed: 10748234
Nat Methods. 2008 Sep;5(9):805-11
pubmed: 19160515
Immunity. 2014 May 15;40(5):692-705
pubmed: 24792914
Sci Signal. 2015 Sep 29;8(396):ra97
pubmed: 26420908
J Gen Physiol. 2002 Jul;120(1):29-37
pubmed: 12084773
Nat Rev Neurol. 2014 Apr;10(4):225-38
pubmed: 24638138
Lancet Neurol. 2016 Sep;15(10):1003-4
pubmed: 27571145
Int J Mol Sci. 2017 Feb 08;18(2):
pubmed: 28208701
Exp Neurol. 2014 Dec;262 Pt A:18-27
pubmed: 24681001
Lancet Neurol. 2016 Sep;15(10):1089-102
pubmed: 27571160
J Neuroinflammation. 2013 Oct 05;10:121
pubmed: 24093512
Eur J Neurol. 2015 Oct;22 Suppl 2:3-13
pubmed: 26374508
Immunity. 2015 Dec 15;43(6):1040-51
pubmed: 26682981
Immunity. 2004 May;20(5):577-88
pubmed: 15142526
Nat Methods. 2013 Feb;10(2):162-70
pubmed: 23314171
Immunol Rev. 2009 Sep;231(1):59-87
pubmed: 19754890
Brain. 2009 May;132(Pt 5):1247-58
pubmed: 19179377
Nature. 1993 Jul 22;364(6435):346-9
pubmed: 8332193
J Neurochem. 2016 Mar;136(5):971-80
pubmed: 26662167
Brain. 2009 Sep;132(Pt 9):2501-16
pubmed: 19570851
Nat Med. 2007 Oct;13(10):1173-5
pubmed: 17828272
J Neural Transm (Vienna). 2017 Jul;124(7):775-798
pubmed: 28236206
Sci Rep. 2016 Oct 05;6:34749
pubmed: 27703262
Biophys J. 2012 May 16;102(10):2401-10
pubmed: 22677394
Handb Clin Neurol. 2014;122:101-13
pubmed: 24507515
J Exp Med. 2005 Jan 17;201(2):233-40
pubmed: 15657292
FEBS J. 2014 Aug;281(15):3433-45
pubmed: 24924920
Cell Motil Cytoskeleton. 2000 Jun;46(2):95-107
pubmed: 10891855
Ann Neurol. 2011 Feb;69(2):292-302
pubmed: 21387374
Acta Neuropathol. 2015 May;129(5):625-37
pubmed: 25716179
J Neuroimmune Pharmacol. 2015 Dec;10(4):528-46
pubmed: 25946987
Rev Neurosci. 2013;24(1):71-88
pubmed: 23152401
Nat Commun. 2014 Apr 16;5:3633
pubmed: 24736453
Nature. 2003 Feb 13;421(6924):744-8
pubmed: 12610626
Annu Rev Immunol. 2015;33:291-353
pubmed: 25861976
J Immunol. 2015 Aug 15;195(4):1399-1407
pubmed: 26150529
Curr Opin Chem Biol. 2017 Jun;38:97-107
pubmed: 28412597
J Immunol. 2006 Jul 1;177(1):566-73
pubmed: 16785554
Biochim Biophys Acta. 2016 Mar;1862(3):461-71
pubmed: 26527183
Exp Neurol. 2010 Sep;225(1):9-17
pubmed: 19961850
Arch Neurol. 2003 Aug;60(8):1082-8
pubmed: 12925363
Immunity. 2010 Sep 24;33(3):424-36
pubmed: 20870176
FASEB J. 2010 Apr;24(4):1023-34
pubmed: 19940258
Mol Neurobiol. 2009 Dec;40(3):289-306
pubmed: 19844813
J Immunol. 2016 May 1;196(9):3618-30
pubmed: 27022197
J Nutr. 2001 Sep;131(9 Suppl):2515S-22S; discussion 2523S-4S
pubmed: 11533304
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13942-7
pubmed: 11717451
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Ther Adv Neurol Disord. 2013 Sep;6(5):322-36
pubmed: 23997817
Nat Commun. 2014 Dec 16;5:5683
pubmed: 25511170
Methods Mol Biol. 2013;1020:215-21
pubmed: 23709036
J Immunol. 2008 Mar 15;180(6):3866-73
pubmed: 18322194
EBioMedicine. 2017 Feb;16:41-50
pubmed: 28161400
Eur J Immunol. 2012 Feb;42(2):470-5
pubmed: 22120889
Trends Immunol. 2013 Mar;34(3):114-9
pubmed: 23116549
J Neurosci. 2001 Oct 1;21(19):7455-62
pubmed: 11567035